Suppr超能文献

门诊超声成像在肩部撞击症诊断和治疗中的作用:一项随机前瞻性研究。

Impact of outpatient clinic ultrasound imaging in the diagnosis and treatment for shoulder impingement: a randomized prospective study.

作者信息

Saeed Aamir, Khan Mumtaz, Morrissey Siobhan, Kane David, Fraser Alexander Duncan

机构信息

Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin 24, Ireland,

出版信息

Rheumatol Int. 2014 Apr;34(4):503-9. doi: 10.1007/s00296-013-2892-z. Epub 2013 Nov 5.

Abstract

The use of musculoskeletal ultrasonography (MSUS) in guiding subdeltoid injection has been shown to improve outcome up to 6 weeks in a few small studies. A recent meta-analysis identified the need for further studies with longer-term outcome and larger sample size. This randomized prospective study assessed whether clinic-based MSUS can significantly improve diagnostic accuracy in shoulder pain and whether MSUS-guided shoulder injection results in improved long-term outcomes. One hundred consecutive patients with 125 painful shoulders were recruited. Patients were randomized to receive either sonographic assessment with consequent palpation-guided injection (Group 1, n = 66) or sonographic assessment with a MSUS-guided injection of 40 mg of methylprednisolone acetate (Group 2, n = 59). A blinded rheumatologist (ADF) performed clinical assessments at baseline, 6 and 12 weeks including shoulder function tests (SFTs) (Hawkins-Kennedy test, supraspinatus tendon tenderness), physician global assessment (PGA) and patient visual analogue scores (VAS) for pain (0-10). Eighty patients with 90 symptomatic shoulders completed 12-week follow-up. Twenty patients, 11 (20 shoulders) from the palpation-guided group and 9 (15 shoulders) from the MSUS-guided group, were excluded at 6 weeks either due to requirement for repeat injection or due to surgical referral. Mean age for patients was 57.7 years, and 65 % patients were female; mean shoulder pain duration was 18 weeks (range 14-22 weeks). SFTs, patient VAS and PGA scores for pain improved significantly from baseline in both groups with significantly greater improvements in the MSUS-guided group (44 shoulders) compared to the palpation-guided group (46 shoulders) in all parameters at 6 (p < 0.01) and 12 weeks (p < 0.05). The use of MSUS in guiding subdeltoid injection has been shown to improve outcome up to 6 weeks in a few small studies. A recent meta-analysis identified the need for further studies with longer-term outcome and larger sample size.

摘要

在一些小型研究中,已表明使用肌肉骨骼超声检查(MSUS)引导三角肌下注射可在长达6周的时间内改善治疗效果。最近的一项荟萃分析指出,需要开展更多关于长期治疗效果及更大样本量的研究。这项随机前瞻性研究评估了基于临床的MSUS是否能显著提高肩部疼痛的诊断准确性,以及MSUS引导下的肩部注射是否能带来更好的长期治疗效果。研究招募了100例连续患者,共125个疼痛肩部。患者被随机分为两组,一组接受超声评估并随后进行触诊引导注射(第1组,n = 66),另一组接受超声评估并在MSUS引导下注射40mg醋酸甲泼尼龙(第2组,n = 59)。一位盲法风湿病学家(ADF)在基线、6周和12周时进行临床评估,包括肩部功能测试(SFTs)(霍金斯 - 肯尼迪试验、冈上肌腱压痛)、医生整体评估(PGA)以及患者疼痛视觉模拟评分(VAS)(0 - 10分)。80例患者共90个有症状的肩部完成了12周的随访。20例患者,其中触诊引导组11例(20个肩部),MSUS引导组9例(15个肩部),在6周时因需要重复注射或手术转诊而被排除。患者的平均年龄为57.7岁,65%为女性;平均肩部疼痛持续时间为18周(范围14 - 22周)。两组的SFTs、患者VAS和PGA疼痛评分均较基线有显著改善,在6周(p < 0.01)和12周(p < 0.05)时,MSUS引导组(44个肩部)在所有参数上的改善均显著大于触诊引导组(46个肩部)。在一些小型研究中,已表明使用MSUS引导三角肌下注射可在长达6周的时间内改善治疗效果。最近的一项荟萃分析指出,需要开展更多关于长期治疗效果及更大样本量的研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验